Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1992 Mar;156(3):281–286.

Blood-brain barrier and new approaches to brain drug delivery.

W M Pardridge 1, R J Boado 1, K L Black 1, P A Cancilla 1
PMCID: PMC1003235  PMID: 1595245

Abstract

Morbidity caused by brain dysfunction affects more than 50 million persons in the United States. Although new neuropharmaceuticals have the potential for treating specific brain diseases, they may not effectively enter brain from blood. Safe strategies are needed for drug delivery through the brain capillary wall, which makes up the blood-brain barrier in vivo. Two of these strategies are reviewed, as are related new developments in the molecular and cell biology of the brain capillary endothelium. The production of chimeric peptides represents a physiologic-based strategy for drug delivery. It entails the covalent coupling of the neuropharmaceutical to a brain transport vector, allowing transportation through the blood-brain barrier. Another strategy is biochemical opening of the blood-brain barrier: intracarotid leukotriene infusion is a method for selectively increasing blood-brain barrier permeability in brain tumors without affecting barrier permeability in normal brain tissue.

Full text

PDF
281

Images in this article

283Image
on p.283

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aharony D., Dobson P. Discriminative effect of gamma-glutamyl transpeptidase inhibitors on metabolism of leukotriene C4 in peritoneal cells. Life Sci. 1984 Nov 19;35(21):2135–2142. doi: 10.1016/0024-3205(84)90513-7. [DOI] [PubMed] [Google Scholar]
  2. Aird R. B. A study of intrathecal, cerebrospinal fluid-to-brain exchange. Exp Neurol. 1984 Nov;86(2):342–358. doi: 10.1016/0014-4886(84)90192-4. [DOI] [PubMed] [Google Scholar]
  3. Baba T., Black K. L., Ikezaki K., Chen K. N., Becker D. P. Intracarotid infusion of leukotriene C4 selectively increases blood-brain barrier permeability after focal ischemia in rats. J Cereb Blood Flow Metab. 1991 Jul;11(4):638–643. doi: 10.1038/jcbfm.1991.115. [DOI] [PubMed] [Google Scholar]
  4. Barnwell J. W., Asch A. S., Nachman R. L., Yamaya M., Aikawa M., Ingravallo P. A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes. J Clin Invest. 1989 Sep;84(3):765–772. doi: 10.1172/JCI114234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Beck D. W., Hart M. N., Cancilla P. A. The role of the macrophage in microvascular regeneration following brain injury. J Neuropathol Exp Neurol. 1983 Nov;42(6):601–614. doi: 10.1097/00005072-198311000-00001. [DOI] [PubMed] [Google Scholar]
  6. Beck D. W., Vinters H. V., Hart M. N., Cancilla P. A. Glial cells influence polarity of the blood-brain barrier. J Neuropathol Exp Neurol. 1984 May;43(3):219–224. doi: 10.1097/00005072-198405000-00001. [DOI] [PubMed] [Google Scholar]
  7. Black K. L., Hoff J. T., McGillicuddy J. E., Gebarski S. S. Increased leukotriene C4 and vasogenic edema surrounding brain tumors in humans. Ann Neurol. 1986 Jun;19(6):592–595. doi: 10.1002/ana.410190613. [DOI] [PubMed] [Google Scholar]
  8. Black K. L., King W. A., Ikezaki K. Selective opening of the blood-tumor barrier by intracarotid infusion of leukotriene C4. J Neurosurg. 1990 Jun;72(6):912–916. doi: 10.3171/jns.1990.72.6.0912. [DOI] [PubMed] [Google Scholar]
  9. Blasberg R. G., Patlak C., Fenstermacher J. D. Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion. J Pharmacol Exp Ther. 1975 Oct;195(1):73–83. [PubMed] [Google Scholar]
  10. Boado R. J., Pardridge W. M. The brain-type glucose transporter mRNA is specifically expressed at the blood-brain barrier. Biochem Biophys Res Commun. 1990 Jan 15;166(1):174–179. doi: 10.1016/0006-291x(90)91927-k. [DOI] [PubMed] [Google Scholar]
  11. Broadwell R. D., Balin B. J., Salcman M. Transcytotic pathway for blood-borne protein through the blood-brain barrier. Proc Natl Acad Sci U S A. 1988 Jan;85(2):632–636. doi: 10.1073/pnas.85.2.632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cancilla P. A., DeBault L. E. Freeze injury and repair of cerebral microvessels. Adv Exp Med Biol. 1980;131:257–269. doi: 10.1007/978-1-4684-3752-2_20. [DOI] [PubMed] [Google Scholar]
  13. Cancilla P. A., Frommes S. P., Kahn L. E., DeBault L. E. Regeneration of cerebral microvessels: a morphologic and histochemical study after local freeze-injury. Lab Invest. 1979 Jan;40(1):74–82. [PubMed] [Google Scholar]
  14. DeBault L. E. gamma-Glutamyltranspeptidase induction mediated by glial foot process-to endothelium contact in co-culture. Brain Res. 1981 Sep 14;220(2):432–435. doi: 10.1016/0006-8993(81)91238-5. [DOI] [PubMed] [Google Scholar]
  15. Duffy K. R., Pardridge W. M. Blood-brain barrier transcytosis of insulin in developing rabbits. Brain Res. 1987 Sep 8;420(1):32–38. doi: 10.1016/0006-8993(87)90236-8. [DOI] [PubMed] [Google Scholar]
  16. Duffy K. R., Pardridge W. M., Rosenfeld R. G. Human blood-brain barrier insulin-like growth factor receptor. Metabolism. 1988 Feb;37(2):136–140. doi: 10.1016/s0026-0495(98)90007-5. [DOI] [PubMed] [Google Scholar]
  17. Estrada C., Bready J. V., Berliner J. A., Pardridge W. M., Cancilla P. A. Astrocyte growth stimulation by a soluble factor produced by cerebral endothelial cells in vitro. J Neuropathol Exp Neurol. 1990 Nov;49(6):539–549. doi: 10.1097/00005072-199011000-00001. [DOI] [PubMed] [Google Scholar]
  18. Farrell C. L., Pardridge W. M. Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: an electron microscopic immunogold study. Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5779–5783. doi: 10.1073/pnas.88.13.5779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Farrell C. L., Yang J., Pardridge W. M. GLUT-1 glucose transporter is present within apical and basolateral membranes of brain epithelial interfaces and in microvascular endothelia with and without tight junctions. J Histochem Cytochem. 1992 Feb;40(2):193–199. doi: 10.1177/40.2.1552163. [DOI] [PubMed] [Google Scholar]
  20. Fenstermacher J. D., Cowles A. L. Theoretic limitations of intracarotid infusions in brain tumor chemotherapy. Cancer Treat Rep. 1977 Jul;61(4):519–526. [PubMed] [Google Scholar]
  21. Fishman J. B., Rubin J. B., Handrahan J. V., Connor J. R., Fine R. E. Receptor-mediated transcytosis of transferrin across the blood-brain barrier. J Neurosci Res. 1987;18(2):299–304. doi: 10.1002/jnr.490180206. [DOI] [PubMed] [Google Scholar]
  22. Friden P. M., Walus L. R., Musso G. F., Taylor M. A., Malfroy B., Starzyk R. M. Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4771–4775. doi: 10.1073/pnas.88.11.4771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gregoriadis G. The carrier potential of liposomes in biology and medicine (first of two parts). N Engl J Med. 1976 Sep 23;295(13):704–710. doi: 10.1056/NEJM197609232951305. [DOI] [PubMed] [Google Scholar]
  24. Groothuis D. R., Fischer J. M., Lapin G., Bigner D. D., Vick N. A. Permeability of different experimental brain tumor models to horseradish peroxidase. J Neuropathol Exp Neurol. 1982 Mar;41(2):164–185. doi: 10.1097/00005072-198203000-00006. [DOI] [PubMed] [Google Scholar]
  25. Harbaugh R. E. Nerve growth factor as a potential treatment in Alzheimer's disease. Biomed Pharmacother. 1989;43(7):483–485. doi: 10.1016/0753-3322(89)90108-x. [DOI] [PubMed] [Google Scholar]
  26. Janzer R. C., Raff M. C. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature. 1987 Jan 15;325(6101):253–257. doi: 10.1038/325253a0. [DOI] [PubMed] [Google Scholar]
  27. Jefferies W. A., Brandon M. R., Hunt S. V., Williams A. F., Gatter K. C., Mason D. Y. Transferrin receptor on endothelium of brain capillaries. Nature. 1984 Nov 8;312(5990):162–163. doi: 10.1038/312162a0. [DOI] [PubMed] [Google Scholar]
  28. Juranka P. F., Zastawny R. L., Ling V. P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins. FASEB J. 1989 Dec;3(14):2583–2592. doi: 10.1096/fasebj.3.14.2574119. [DOI] [PubMed] [Google Scholar]
  29. Krause D., Vatter B., Dermietzel R. Immunochemical and immunocytochemical characterization of a novel monoclonal antibody recognizing a 140 kDa protein in cerebral pericytes of the rat. Cell Tissue Res. 1988 Jun;252(3):543–555. doi: 10.1007/BF00216641. [DOI] [PubMed] [Google Scholar]
  30. Kumagai A. K., Eisenberg J. B., Pardridge W. M. Absorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport. J Biol Chem. 1987 Nov 5;262(31):15214–15219. [PubMed] [Google Scholar]
  31. Levi-Montalcini R., Angeletti P. U. Nerve growth factor. Physiol Rev. 1968 Jul;48(3):534–569. doi: 10.1152/physrev.1968.48.3.534. [DOI] [PubMed] [Google Scholar]
  32. MacDonald P. N., Bok D., Ong D. E. Localization of cellular retinol-binding protein and retinol-binding protein in cells comprising the blood-brain barrier of rat and human. Proc Natl Acad Sci U S A. 1990 Jun;87(11):4265–4269. doi: 10.1073/pnas.87.11.4265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Marx J. NGF and Alzheimer's: hopes and fears. Science. 1990 Jan 26;247(4941):408–410. doi: 10.1126/science.2405484. [DOI] [PubMed] [Google Scholar]
  34. Maxwell K., Berliner J. A., Cancilla P. A. Induction of gamma-glutamyl transpeptidase in cultured cerebral endothelial cells by a product released by astrocytes. Brain Res. 1987 May 5;410(2):309–314. doi: 10.1016/0006-8993(87)90329-5. [DOI] [PubMed] [Google Scholar]
  35. Minakawa T., Bready J., Berliner J., Fisher M., Cancilla P. A. In vitro interaction of astrocytes and pericytes with capillary-like structures of brain microvessel endothelium. Lab Invest. 1991 Jul;65(1):32–40. [PubMed] [Google Scholar]
  36. Nakagawa H., Groothuis D., Blasberg R. G. The effect of graded hypertonic intracarotid infusions on drug delivery to experimental RG-2 gliomas. Neurology. 1984 Dec;34(12):1571–1581. doi: 10.1212/wnl.34.12.1571. [DOI] [PubMed] [Google Scholar]
  37. Neuwelt E. A., Barnett P. A., Bigner D. D., Frenkel E. P. Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier. Proc Natl Acad Sci U S A. 1982 Jul;79(14):4420–4423. doi: 10.1073/pnas.79.14.4420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Neuwelt E. A., Barnett P. A., McCormick C. I., Frenkel E. P., Minna J. D. Osmotic blood-brain barrier modification: monoclonal antibody, albumin, and methotrexate delivery to cerebrospinal fluid and brain. Neurosurgery. 1985 Sep;17(3):419–423. doi: 10.1227/00006123-198509000-00004. [DOI] [PubMed] [Google Scholar]
  39. Neuwelt E. A., Hill S. A., Frenkel E. P. Osmotic blood-brain barrier modification and combination chemotherapy: concurrent tumor regression in areas of barrier opening and progression in brain regions distant to barrier opening. Neurosurgery. 1984 Sep;15(3):362–366. doi: 10.1227/00006123-198409000-00011. [DOI] [PubMed] [Google Scholar]
  40. Neuwelt E. A., Rapoport S. I. Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors. Fed Proc. 1984 Feb;43(2):214–219. [PubMed] [Google Scholar]
  41. Papandrikopoulou A., Frey A., Gassen H. G. Cloning and expression of gamma-glutamyl transpeptidase from isolated porcine brain capillaries. Eur J Biochem. 1989 Aug 15;183(3):693–698. doi: 10.1111/j.1432-1033.1989.tb21100.x. [DOI] [PubMed] [Google Scholar]
  42. Pardridge W. M., Boado R. J., Farrell C. R. Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization. J Biol Chem. 1990 Oct 15;265(29):18035–18040. [PubMed] [Google Scholar]
  43. Pardridge W. M., Buciak J. L., Friden P. M. Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo. J Pharmacol Exp Ther. 1991 Oct;259(1):66–70. [PubMed] [Google Scholar]
  44. Pardridge W. M., Eisenberg J., Yang J. Human blood-brain barrier insulin receptor. J Neurochem. 1985 Jun;44(6):1771–1778. doi: 10.1111/j.1471-4159.1985.tb07167.x. [DOI] [PubMed] [Google Scholar]
  45. Pardridge W. M., Eisenberg J., Yang J. Human blood-brain barrier transferrin receptor. Metabolism. 1987 Sep;36(9):892–895. doi: 10.1016/0026-0495(87)90099-0. [DOI] [PubMed] [Google Scholar]
  46. Pardridge W. M., Oldendorf W. H., Cancilla P., Frank H. J. Blood-brain barrier: interface between internal medicine and the brain. Ann Intern Med. 1986 Jul;105(1):82–95. doi: 10.7326/0003-4819-105-1-82. [DOI] [PubMed] [Google Scholar]
  47. Pardridge W. M. Receptor-mediated peptide transport through the blood-brain barrier. Endocr Rev. 1986 Aug;7(3):314–330. doi: 10.1210/edrv-7-3-314. [DOI] [PubMed] [Google Scholar]
  48. Pardridge W. M., Triguero D., Buciak J. L. Beta-endorphin chimeric peptides: transport through the blood-brain barrier in vivo and cleavage of disulfide linkage by brain. Endocrinology. 1990 Feb;126(2):977–984. doi: 10.1210/endo-126-2-977. [DOI] [PubMed] [Google Scholar]
  49. Pardridge W. M., Triguero D., Buciak J. Transport of histone through the blood-brain barrier. J Pharmacol Exp Ther. 1989 Dec;251(3):821–826. [PubMed] [Google Scholar]
  50. Pardridge W. M., Triguero D., Buciak J., Yang J. Evaluation of cationized rat albumin as a potential blood-brain barrier drug transport vector. J Pharmacol Exp Ther. 1990 Nov;255(2):893–899. [PubMed] [Google Scholar]
  51. Pardridge W. M., Yang J., Eisenberg J. Blood-brain barrier protein phosphorylation and dephosphorylation. J Neurochem. 1985 Oct;45(4):1141–1147. doi: 10.1111/j.1471-4159.1985.tb05534.x. [DOI] [PubMed] [Google Scholar]
  52. Seulberger H., Lottspeich F., Risau W. The inducible blood--brain barrier specific molecule HT7 is a novel immunoglobulin-like cell surface glycoprotein. EMBO J. 1990 Jul;9(7):2151–2158. doi: 10.1002/j.1460-2075.1990.tb07384.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Solhonne B., Gros C., Pollard H., Schwartz J. C. Major localization of aminopeptidase M in rat brain microvessels. Neuroscience. 1987 Jul;22(1):225–232. doi: 10.1016/0306-4522(87)90212-0. [DOI] [PubMed] [Google Scholar]
  54. Soter N. A., Lewis R. A., Corey E. J., Austen K. F. Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin. J Invest Dermatol. 1983 Feb;80(2):115–119. doi: 10.1111/1523-1747.ep12531738. [DOI] [PubMed] [Google Scholar]
  55. Sternberger N. H., Sternberger L. A. Blood-brain barrier protein recognized by monoclonal antibody. Proc Natl Acad Sci U S A. 1987 Nov;84(22):8169–8173. doi: 10.1073/pnas.84.22.8169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Stewart P. A., Wiley M. J. Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: a study using quail--chick transplantation chimeras. Dev Biol. 1981 May;84(1):183–192. doi: 10.1016/0012-1606(81)90382-1. [DOI] [PubMed] [Google Scholar]
  57. Tao-Cheng J. H., Brightman M. W. Development of membrane interactions between brain endothelial cells and astrocytes in vitro. Int J Dev Neurosci. 1988;6(1):25–37. doi: 10.1016/0736-5748(88)90026-3. [DOI] [PubMed] [Google Scholar]
  58. Tomiwa K., Hazama F., Mikawa H. Neurotoxicity of vincristine after the osmotic opening of the blood-brain barrier. Neuropathol Appl Neurobiol. 1983 Sep-Oct;9(5):345–354. doi: 10.1111/j.1365-2990.1983.tb00120.x. [DOI] [PubMed] [Google Scholar]
  59. Triguero D., Buciak J. B., Yang J., Pardridge W. M. Blood-brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native protein. Proc Natl Acad Sci U S A. 1989 Jun;86(12):4761–4765. doi: 10.1073/pnas.86.12.4761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Weiler-Güttler H., Sommerfeldt M., Papandrikopoulou A., Mischek U., Bonitz D., Frey A., Grupe M., Scheerer J., Gassen H. G. Synthesis of apolipoprotein A-1 in pig brain microvascular endothelial cells. J Neurochem. 1990 Feb;54(2):444–450. doi: 10.1111/j.1471-4159.1990.tb01892.x. [DOI] [PubMed] [Google Scholar]
  61. Weiler-Güttler H., Zinke H., Möckel B., Frey A., Gassen H. G. cDNA cloning and sequence analysis of the glucose transporter from porcine blood-brain barrier. Biol Chem Hoppe Seyler. 1989 May;370(5):467–473. doi: 10.1515/bchm3.1989.370.1.467. [DOI] [PubMed] [Google Scholar]
  62. Whelan J. P., Eriksson U., Lampson L. A. Expression of mouse beta 2-microglobulin in frozen and formaldehyde-fixed central nervous tissues: comparison of tissue behind the blood-brain barrier and tissue in a barrier-free region. J Immunol. 1986 Oct 15;137(8):2561–2566. [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES